Clinical Trials Logo

Obesity in Diabetes clinical trials

View clinical trials related to Obesity in Diabetes.

Filter by:
  • None
  • Page 1

NCT ID: NCT02959762 Active, not recruiting - Obesity Clinical Trials

Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)

Start date: October 2016
Phase: N/A
Study type: Interventional

Animal studies have found that vitamin K-dependent proteins matrix Gla protein and osteocalcin beneficially influence lipid and glucose metabolism, respectively. However, this concept has not been tested in humans at risk for dyslipidemia and diabetes risk. Vitamin K supplementation presents an opportunity to test the hypothesized link between the vitamin K-dependent proteins and markers of lipid and glucose metabolism. The investigators will conduct an 8-week vitamin K intervention (to manipulate carboxylation of matrix Gla protein and osteocalcin) and determine its effects on markers of dyslipidemia and diabetes risk. Sixty obese children will be randomly allocated to either the control group receiving placebo or the low-dose (45 mcg/d) or high-dose group (90 mcg/d) receiving vitamin K (menaquinone-7).

NCT ID: NCT00029848 Completed - Obesity Clinical Trials

Obese Patients With Type 2 Diabetes

RIO-Diabetes
Start date: October 2001
Phase: Phase 3
Study type: Interventional

To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with Type 2 Diabetes